Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04015102 · ClinicalTrials.gov registry record
A Registry for Hereditary Cancer Risk Assessment and Genetic Testing
A clinical trial, sponsored by Myriad Genetic Laboratories.
- Completed
- Registry status
- 255
- Enrollment target
NCT04015102: Completed study, sponsored by Myriad Genetic Laboratories.
NCT04015102 is a clinical trial that has completed, run by Myriad Genetic Laboratories. The registered enrollment target is 255 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04015102 has completed, sponsored by Myriad Genetic Laboratories.
- COMPLETED
- Registry status
- 255 participants
- Enrollment target
Study Summary
This prospective registry will evaluate the feasibility and impact of implementing standard cancer family history review and guideline-aligned genetic testing for men diagnosed with Prostate Cancer in community urology practices nationwide.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2019-03-06 |
| Est. Completion | 2020-10-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04015102
The ClinicalTrials.gov registry entry for NCT04015102 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 255 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Myriad Genetic Laboratories, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04015102 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04015102 about?
NCT04015102 is a clinical study titled "A Registry for Hereditary Cancer Risk Assessment and Genetic Testing". This prospective registry will evaluate the feasibility and impact of implementing standard cancer family history review and guideline-aligned genetic testing for men diagnosed with Prostate Cancer in community urology practices nationwide.
What is the current status of trial NCT04015102?
This trial is currently completed. The enrollment target is 255 participants. The study started on 2019-03-06. Estimated completion is 2020-10-30.
Who is sponsoring clinical trial NCT04015102?
This trial is sponsored by Myriad Genetic Laboratories, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.